A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas
Journal article published in 2016 by
W. Fiedler 
,
S. DeDosso,
S. Cresta ,
J. Weidmann,
A. Tessari,
M. Salzberg,
B. Dietrich,
H. Baumeister,
S. Goletz,
L. Gianni ,
C. Sessa
,
S. DeDosso,
S. Cresta ,
J. Weidmann,
A. Tessari,
M. Salzberg,
B. Dietrich,
H. Baumeister,
S. Goletz,
L. Gianni ,
C. Sessa
